Walleye Capital
HRMY icon

Walleye Capital’s Harmony Biosciences HRMY Stock Holding History

Walleye Capital’s Portfolio HRMY Stock Details HRMY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.62M Buy
+44,372
New +$1.4M 0.01% 1710
2026
Q1 		– Sell
-141,769
Closed -$5.3M – 4651
2025
Q4 		$5.3M Buy
+141,769
New +$4.66M 0.02% 1115
2023
Q3 		– Sell
-196,200
Closed -$6.9M – 5059
2023
Q2 		$6.9M Buy
196,200
+155,656
+384% +$5.37M 0.03% 567
2023
Q1 		$1.32M Buy
+40,544
New +$1.85M 0.02% 973

Other funds holding HRMY

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
American Century Companies
American Century Companies Kansas City, Missouri $226B AUM 44.75% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
LSV Asset Management
LSV Asset Management Chicago, Illinois $55.1B AUM 45.38% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
AC
Armistice Capital New York $8.17B AUM 68.82% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Walleye Capital's HRMY Position: Q2 2026 in Review

Walleye Capital opened a new position in Harmony Biosciences (HRMY) in Q2 2026: 44,372 shares worth $1.62M. The stake represents 0.01% of the portfolio and ranks #1710 among its holdings. This is a return to the name: Walleye Capital previously reported a position in HRMY as recently as Q4 2025.

Walleye Capital first reported a position in HRMY in Q1 2023 and has held it in 4 quarters since. The position peaked at $6.9M in Q2 2023. 327 funds tracked by Wall St. Rank hold HRMY as of Q2 2026.

  • Walleye Capital held 44,372 shares of Harmony Biosciences worth $1.62M as of Q2 2026.
  • Harmony Biosciences was a new Walleye Capital position in Q2 2026.
  • Harmony Biosciences made up 0.01% of Walleye Capital's portfolio in Q2 2026, its #1710 holding.
  • Walleye Capital first reported a position in Harmony Biosciences in Q1 2023 and has held it in 4 quarters since.
  • Walleye Capital's Harmony Biosciences position peaked at $6.9M in Q2 2023.
  • 327 funds tracked by Wall St. Rank held Harmony Biosciences as of Q2 2026.

Based on Walleye Capital's 13F filing for Q2 2026, filed 3 Aug 2026.